Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Blossom Innovations
AddedFeb 15, 2024
UpdatedJun 18, 2026
Blossom Innovations

Blossom Innovations

Series A

Blossom Innovations: Transforming early-stage scientific ideas into novel medical technologies.

HQ
Boston, MA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Blossom Innovations, founded with a mission to transform early-stage scientific ideas into novel medical technologies, focuses on developing cutting-edge solutions for unmet clinical needs in dermatology. The company leverages an interdisciplinary team and strong partnerships to advance disruptive innovations from concept to clinic. Their portfolio includes novel device technologies and groundbreaking drug/device combinations aimed at improving patient care.

Notable affiliated people and investors include leading experts in medical technology and venture capital firms specializing in healthcare innovation. Blossom Innovations has achieved significant milestones, including successful clinical trials and regulatory approvals for their products. Their impact is evident in the improved treatment options available to patients and the advancement of medical technology in dermatology.

Blossom Innovations - Similar Companies

BlossomHill Therapeutics logo

BlossomHill Therapeutics

bhtherapeutics.com

Celdara Medical logo

Celdara Medical

DermBiont logo

DermBiont

dermbiont.com

Alopexx logo

Alopexx

alopexx.com

BiomedInnovations logo

BiomedInnovations

Early Bird Medical logo

Early Bird Medical

earlybirdmed.com

ExploraMed NC7 logo

ExploraMed NC7

exploramed.com

Distinct Dermatology logo

Distinct Dermatology

Foundry logo

Foundry

thefoundry.com

Aesthetics Biomedical logo

Aesthetics Biomedical

eLum Technologies logo

eLum Technologies

BioInspire Technologies logo

BioInspire Technologies

LifeSprout logo

LifeSprout

lifesproutbio.com

Curie.Bio logo

Curie.Bio

curie.bio

Boomerang Medical logo

Boomerang Medical

Blossom Innovations - Quick Facts

Who are Blossom Innovations' competitors?

Companies similar to Blossom Innovations include BlossomHill Therapeutics, Celdara Medical, DermBiont and Alopexx.

When was Blossom Innovations founded?

Blossom Innovations was founded in 2011.

Where is Blossom Innovations' headquarters located?

Blossom Innovations' headquarters is located in Boston, MA, US.

When was Blossom Innovations' last funding round?

Blossom Innovations' most recent funding round was for $9M (USD) in May 2017.

How much has Blossom Innovations raised to-date?

As of May 24, 2017, Blossom Innovations has raised a total of $9M (USD).

How many employees does Blossom Innovations have?

Blossom Innovations has 14 employees as of Feb 5, 2024.

Blossom Innovations - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified